We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

These two FTSE 100 dividends stars still look cheap

These two FTSE 100 (INDEXFTSE: UKX) firms look like safe dividend champions but still appear to be undervalued.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In today’s low-interest rate world, it’s difficult to find undervalued dividend champions. The rush for yield has sent investors charging into dividend stocks globally and now you have to do your homework if you want to find a high, sustainable dividend yield with room for growth.

It’s generally accepted that if a stock has a dividend yield more than the market average, the market believes the payout is unsustainable. This isn’t always the case however, and there are plenty of companies out there with a dividend yield more than the FTSE 100 average, which are unlikely to cut their payout any time soon.

XXX

National Grid (LSE: NG) and AstraZeneca (LSE: AZN) are two great examples. At present, the FTSE 100 supports an average dividend yield of 3.7%, but both of these dividend champions yield more than 4%. There appears to be no risk to either company’s dividend payout either.

The UK’s best dividend stock?

National Grid is probably the UK’s top dividend stock. The company runs the country’s electricity distribution network, a highly defensive business with almost no competitors. Pre-tax profits have grown steadily in line with inflation over the past decade, and thanks to margin expansion earnings per share have increased by more than 20% since 2012.

Management has steadily increased National Grid’s dividend payout per share to investors in line with earnings per share. Since 2012 the payout has grown by around 10% and the payout is currently covered 1.5 times by earnings per share. This conservative dividend policy gives the company plenty of flexibility. If earnings begin to fall, there will be no immediate pressure on the payout. 

At present, the shares support that dividend yield of 4%, which is significantly more than the interest rate you get on most savings accounts today. City analysts expect the payout to rise by 1p per share or 2% next year. Shares in National Grid currently trade at a forward P/E of 17.1.

Stuck in a rut 

AstraZeneca’s dividend payout has been stuck in a rut for the past five years. Management took the prudent decision to hold the payout at a certain level back in 2011 when earnings began to slide after the company lost the exclusive manufacturing rights to some key treatments. Pre-tax profits have more than halved over the past five years, yet the company’s dividend payout to shareholders remains well covered by earnings per share. 

Specifically, shares in the company currently support a dividend yield of 4.2% and the payout is covered 1.5 times by earnings per share. Unfortunately, City analysts expect Astra’s earnings per share to fall a further 3% this year and 3% for 2017. Still, even after these declines the dividend will remain covered around one-and-a-half times by earnings per share. Shares in Astra currently trade at a forward P/E of 16.7.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »